Ptc Therapeutics, Inc. · NASDAQ:PTCT
BlackRock, Inc. reported a 14.80% stake in Ptc Therapeutics, Inc. (Schedule 13G/A)
Event Nov 30, 2025 · Filed Dec 4, 2025
BlackRock, Inc. reported a 14.80% stake in Ptc Therapeutics, Inc., 11,904,696 shares, as a passive investor on Nov 30, 2025. Filed Dec 4, 2025 (Schedule 13G/A).
- Stake
- 14.80%
- Shares
- 11,904,696
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 14.80% | 11,904,696 |
Source
Related
- Ptc Therapeutics, Inc.
- BlackRock, Inc.
- Ptc Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 17, 2025
- Form 4 · Schmertzler Michael · Oct 16, 2026
- Form 4 · Boulding Mark Elliott · Oct 13, 2026
- Form 4 · Schmertzler Michael · Oct 9, 2026
- Form 4 · Boulding Mark Elliott · Oct 7, 2026
- Form 4 · Steele Glenn Jr Md Phd · Oct 2, 2026